Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
<jats:p>With an estimated 25% of the global population infected with <jats:italic>Mycobacterium tuberculosis</jats:italic> (<jats:italic>Mtb</jats:italic>), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatmen...
Main Authors: | Grace, Patricia S, Dolatshahi, Sepideh, Lu, Lenette L, Cain, Adam, Palmieri, Fabrizio, Petrone, Linda, Fortune, Sarah M, Ottenhoff, Tom HM, Lauffenburger, Douglas A, Goletti, Delia, Joosten, Simone A, Alter, Galit |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media SA
2021
|
Online Access: | https://hdl.handle.net/1721.1/136134 |
Similar Items
-
Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
by: Grace, Patricia S, et al.
Published: (2022) -
Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
by: Patricia S. Grace, et al.
Published: (2021-07-01) -
Tuberculosis biomarkers: from diagnosis to protection
by: Delia Goletti, et al.
Published: (2016-06-01) -
A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis
by: Joosten, SA, et al.
Published: (2013) -
IgG subclass and Fc glycosylation shifts are linked to the transition from pre- to inflammatory autoimmune conditions
by: Jana Sophia Buhre, et al.
Published: (2022-11-01)